Buy Full EMAT Report

    Price: €120

 

       

 

 

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

 

► Example of EMAT Report

 

EPSILON M&A DEAL REPORT

Transaction Multiples for the Valuation of Private Companies

Archimica - Valuation Multiples - Pharmaceuticals

Euticals / Archimica

23431
18/11/2011
Exit,Acquisition of Majority Stake
Yes
Euticals

Archimica
Italy
Health, Pharmaceuticals & Biotechnology > Pharmaceuticals & Cosmetics > Pharmaceuticals
Archimica SPA, a pharmaceutical fine chemical company , engages in the custom synthesis of building blocks, pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and generic APIs;...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic - - - -
Current - - - - - -
 
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Pharmaceuticals » = 65
Example of comparable transactions on EMAT (same sub-sector):
DateAcquirerTargetCountryMultiplesSee details
04/07/2011 WCM (2011) William Ransom & Son England
28598
01/06/2011 Vetoquinol Farmagricola Brazil
30412

Source: Epsilon Research / EMAT